Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
22.92
+0.82 (3.71%)
At close: Jul 17, 2026, 4:00 PM EDT
22.90
-0.02 (-0.09%)
After-hours: Jul 17, 2026, 7:59 PM EDT
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of $3.67 billion as of July 17, 2026. Its market cap has increased by 122.96% in one year.
Market Cap
3.67B
Enterprise Value
3.64B
1-Year Change
122.96%
Ranking
Category
Stock Price
$22.92
ChartMarket Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.77B to $3.67B, a decrease of -23.17%. That is a compound annual growth rate of -3.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 3.67B | 47.95% |
| Dec 31, 2025 | 2.48B | 180.23% |
| Dec 31, 2024 | 884.74M | 24.72% |
| Dec 29, 2023 | 709.39M | -35.07% |
| Dec 30, 2022 | 1.09B | -72.41% |
| Dec 31, 2021 | 3.96B | -51.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Qiagen | 8.53B |
| BillionToOne | 5.97B |
| Twist Bioscience | 5.77B |
| Sotera Health Company | 5.18B |
| RadNet | 4.83B |
| Veracyte | 4.75B |
| GRAIL | 3.19B |
| GeneDx Holdings | 1.96B |